Point72 Asset Management’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Hold
0
1659
2025
Q1
Hold
0
1621
2024
Q2
Sell
-28,033
Closed -$1.43M 1592
2024
Q1
$1.43M Buy
+28,033
New +$1.43M ﹤0.01% 903
2023
Q4
Sell
-6,834
Closed -$108K 1843
2023
Q3
$108K Hold
6,834
﹤0.01% 1283
2023
Q2
$113K Hold
6,834
﹤0.01% 1011
2023
Q1
$95.7K Hold
6,834
﹤0.01% 1151
2022
Q4
$69.6K Sell
6,834
-96,377
-93% -$981K ﹤0.01% 938
2022
Q3
$1.32M Buy
103,211
+31,340
+44% +$401K 0.01% 820
2022
Q2
$1.48M Buy
71,871
+10,621
+17% +$219K 0.01% 797
2022
Q1
$2.3M Buy
61,250
+10,710
+21% +$403K 0.01% 776
2021
Q4
$4.87M Buy
50,540
+540
+1% +$52.1K 0.02% 641
2021
Q3
$7.23M Buy
50,000
+5,845
+13% +$845K 0.03% 533
2021
Q2
$8.15M Sell
44,155
-21,275
-33% -$3.93M 0.04% 468
2021
Q1
$16.1M Buy
65,430
+5,644
+9% +$1.39M 0.08% 303
2020
Q4
$16.9M Buy
59,786
+9,801
+20% +$2.76M 0.08% 300
2020
Q3
$12M Buy
49,985
+25,435
+104% +$6.1M 0.06% 354
2020
Q2
$8.15M Sell
24,550
-5,510
-18% -$1.83M 0.05% 365
2020
Q1
$6.84M Buy
30,060
+23,721
+374% +$5.4M 0.06% 331
2019
Q4
$1.56M Buy
+6,339
New +$1.56M 0.01% 613
2018
Q2
Sell
-12,505
Closed -$3.52M 941
2018
Q1
$3.52M Sell
12,505
-3,750
-23% -$1.06M 0.01% 521
2017
Q4
$3.82M Buy
+16,255
New +$3.82M 0.02% 524